With Lawsuit And Medtech Tailwinds - Johnson & Johnson May Be Back [Seeking Alpha]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Seeking Alpha
The company is facing nearly 60,000 lawsuits from ex-talc users claiming that the powder caused their cancer. A US District Judge is allowing the company to contest evidence linking its talc powder to cancer, providing an opportunity for new arguments in its defense. On top of that, the company is working on a transition to fast-growing medtech products and solutions, adding to the attractiveness of its current valuation. Looking for more investing ideas like this one? Get them exclusively at iREIT® on Alpha. Learn More » Introduction Last year, I started covering healthcare giant Johnson & Johnson ( NYSE: JNJ , with my most recent article on the company written on January 4 of this year, titled "Johnson & Johnson: One Of The World's Safest Stocks Could Return +10% Per Year." In that article, I did a number of things, including explaining that its AAA credit rating makes it one of the safest stocks in the world. In fact, this rating is so high, that there's nothing above
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- Justice Department is investigating McKinsey consulting firm's role in opioid epidemic [CNN]CNN
- Are You Looking for a High-Growth Dividend Stock? [Yahoo! Finance]Yahoo! Finance
- Johnson & Johnson receives positive CHMP opinion for RYBREVANT®? (amivantamab) in combination with chemotherapy for the first-line treatment of patients with advanced non-small cell lung cancer with activating EGFR exon 20 insertion mutations [Yahoo! FinaYahoo! Fina
- Neurocrine: Success Continues To Roll In With Positive MDD Treatment Data [Seeking Alpha]Seeking Alpha
- AACN's New Web Resource Focuses on Preparing Nurses with Essential Well-Being and Leadership Competencies [Yahoo! Finance]Yahoo! Finance
JNJ
Earnings
- 4/16/24 - Beat
JNJ
Sec Filings
- 4/16/24 - Form 8-K/A
- 4/16/24 - Form 8-K
- 3/27/24 - Form PX14A6G
- JNJ's page on the SEC website